Best GLP-1 Tracker App for Australian Users in 2026
Track Ozempic, Wegovy, and Mounjaro progress and support PBS access continuation with the best GLP-1 apps for Australian users.
Australia's GLP-1 landscape moved significantly in 2024 and 2025. Ozempic has been PBS-listed for type 2 diabetes for several years. Wegovy (semaglutide 2.4mg) was listed on the PBS for obesity management from late 2024 for patients who meet the qualifying BMI criteria. Mounjaro (tirzepatide) is TGA approved and growing rapidly.
If you are accessing any of these through PBS, tracking matters. Monitoring progress to maintain that access is part of the picture too. PBS access for GLP-1 medications is not unconditional. Your prescriber needs evidence that treatment is producing clinical benefit, and documented weight and symptom trends are how you provide that evidence.
This guide covers the four best options available to Australian GLP-1 users in 2026. For the full comparison of all 7 tracker apps, see the complete GLP-1 Tracker App Guide.
The Quick Answer
For most Australian users, the choice comes down to Shotsy or Regimen. Shotsy is the dominant GLP-1 app by review volume and works well for single-medication tracking on Ozempic or Wegovy. Regimen is the better pick if you are tracking multiple compounds (for instance, if you are on Mounjaro and managing T2D alongside other medications).
Both are available on iOS and Android. Both have free tiers. Shotsy has more GLP-1-specific reviews. Regimen has the edge on multi-compound protocols, health correlation charts, and broader compound support.
The Top 4 Apps, Australian-Framed
1. Regimen: Best for multi-compound Australian users
iOS and Android. Free for one compound, $7.99 AUD/month (roughly) for multi-compound tracking. 4.9 stars (70+ reviews).
If you are managing T2D with Mounjaro and also tracking metformin or blood pressure medication, Regimen handles all of it in one place. The health correlation feature maps your weight trend and symptom patterns (energy, appetite, nausea) against your injection schedule, useful both for your own understanding and for GP conversations about whether the current dose titration is working. The injection scheduling covers Ozempic's weekly 0.25/0.5/1mg titration steps and Wegovy's 0.25 to 2.4mg progression clearly.
Ready to track your protocol?
- Smart reminders so you never miss a dose
- Progress tracking with photos and weight
- Medication level curves for every compound
2. Shotsy: Best for dedicated GLP-1 users
iOS and Android. Freemium with a $16.49 AUD/month premium tier (roughly). 4.85 stars across 19,802 reviews.
Shotsy is the most reviewed GLP-1 tracker by a significant margin. The medication level charts are purpose-built for GLP-1 protocols and map your dose progression in a format that is instantly readable. Most Australian users on single-medication Ozempic or Wegovy protocols will find Shotsy's free tier covers everything they need. The premium cost is higher than Regimen's, but the free tier is genuinely capable.
3. Glapp: Best free option with PK visualisation
Web-only. Free.
Glapp runs in your browser without an app install. It tracks GLP-1 PK curves and includes food noise tracking specifically designed for GLP-1 users. No push reminders is the main limitation for injection scheduling. But it is free, and the PK visualisation is good. A useful tool for users who want zero subscription cost.
4. GLP1 Tracker: Best dedicated tirzepatide tracker
iOS only. Freemium. 4.7 stars across 61 reviews.
GLP1 Tracker is focused on tirzepatide protocols. If you are on Mounjaro and want a tracker purpose-built for tirzepatide's 2.5/5/7.5/10/12.5/15mg titration steps, this covers it well. iOS only, which rules it out for Android users.
Why PBS Tracking Matters in Australia
PBS listing does not mean unconditional long-term access. Your prescriber is responsible for confirming that PBS-listed GLP-1 treatment is producing clinical benefit. For Wegovy's obesity indication, the qualifying criteria include ongoing BMI eligibility and demonstrated response. For Ozempic in T2D, your GP needs to see that glycaemic management is improving.
Tracking gives you the documented evidence that supports both of these. A consistent weight loss trend over 12 to 24 weeks tells a clearer story than recall at a GP appointment. Logged dose titration history, combined with side effect patterns, helps your prescriber understand why you are at the current dose and what the tolerance picture looks like.
For Wegovy specifically: the first few months on a titration schedule are where most people struggle with nausea and GI symptoms. Tracking when those symptoms occur relative to injection day helps you and your prescriber decide whether to hold a dose level longer before titrating up, which is a common and clinically appropriate adjustment.
For a full picture of GLP-1 access in Australia, see the Ozempic and Mounjaro Australia Guide.
Frequently Asked Questions
Is Wegovy available on the PBS in Australia?
Yes, from late 2024. Wegovy (semaglutide 2.4mg) was listed on the PBS for chronic weight management in adults with a qualifying BMI. Eligibility criteria apply. Your GP or specialist will assess whether you meet the requirements.
Does tracking help with PBS GLP-1 access continuation?
Yes. Your prescriber needs to document clinical response to justify continued PBS access. Tracked weight trends and symptom logs give your GP something concrete to reference at review appointments.
Is Regimen available on Android in Australia?
Yes. Regimen is available on both the iOS App Store and Google Play Store. Shotsy is also available on Android. GLP1 Tracker is iOS only.
What's the difference between Ozempic and Wegovy in Australia?
Ozempic (semaglutide 0.5 to 2mg) is PBS-listed for type 2 diabetes management. Wegovy (semaglutide 2.4mg) is PBS-listed for chronic weight management in adults without T2D who meet BMI criteria. Both are semaglutide injections but at different doses and for different indications.
Can I track Mounjaro's tirzepatide dose steps in Regimen?
Yes. Regimen supports tirzepatide alongside semaglutide and other GLP-1 compounds. If you are titrating through Mounjaro's dose steps (2.5 to 15mg), you can log each step change and correlate it with weight progress and side effect patterns.
Track your GLP-1 protocol with Regimen. Ozempic, Wegovy, and Mounjaro supported with weight trends and titration tracking. Free for one compound.
Regimen is a tracking tool, not a medical service. We do not provide medical advice. Always consult your healthcare professional before starting, changing, or stopping any medication protocol.